Association of cognitive dysfunction with cardiovascular disease events in elderly hypertensive patients.


Journal Article

OBJECTIVES: This study assesses whether presence of cognitive dysfunction can be a marker associated with the development of cardiovascular disease (CVD) events independent of ambulatory blood pressure (BP) or other indices of target organ damage (TOD) in elderly hypertensive patients. METHODS: We recruited 585 hypertensive patients (mean age, 73 years; 41% men) who were ambulatory, lived independently, and were without clinically overt dementia. Cognitive function was assessed by Mini-Mental State Examination (MMSE) at baseline, and CVD events (coronary artery disease, stroke, congestive heart failure, and sudden death) were prospectively ascertained. Cognitive dysfunction was defined as the lowest quartile of MMSE scores (n = 183, median 24 points). RESULTS: CVD events occurred in 42 people over an average of 2.8 years (1644 person-years). The prevalence of cognitive dysfunction was higher in patients with CVD events than those without (57 vs. 29%; both P <0.001) at baseline. Cognitive dysfunction was associated with CVD events, after adjustment for nocturnal SBP and evidence of TOD [i.e. albuminuria, cardiac hypertrophy, and carotid-artery intima-media thickness (IMT)], hazard ratio 2.5-2.9 (all P <0.01). Incorporation of MMSE in the risk model (including age, estimated glomerular filtration rate, and preexisting CVD) improved the C-statistics (from 0.691 to 0.741) and resulted in a net reclassification improvement of 17.6% (P = 0.02). In contrast, incorporation of albuminuria, cardiac hypertrophy, and high carotid-artery IMT added little further improvement in the risk prediction. CONCLUSION: Cognitive dysfunction is an independent marker associated with increased risk of CVD events in elderly hypertensive patients.

Full Text

Duke Authors

Cited Authors

  • Yano, Y; Bakris, GL; Inokuchi, T; Ohba, Y; Tamaki, N; Nagata, M; Kuwabara, M; Yokota, N; Eto, T; Kuroki, M; Shimada, K; Kario, K

Published Date

  • February 2014

Published In

Volume / Issue

  • 32 / 2

Start / End Page

  • 423 - 431

PubMed ID

  • 24351802

Pubmed Central ID

  • 24351802

Electronic International Standard Serial Number (EISSN)

  • 1473-5598

Digital Object Identifier (DOI)

  • 10.1097/HJH.0000000000000025


  • eng

Conference Location

  • England